UAS regulatory sequences drive expression of an inverted repeat.
Expression of brJF02585 in the fat body under the control of Scer\GAL4DcG results in significant hyperglycaemia.
Expression of brJF02585 in C-IV neurons under the control of Scer\GAL4ppk.1.9 results in a reduction in total dendritic length in ddaC neurons. The total number of dendritic branches is also reduced in ddaC neurons.
brJF02585, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of EcRB1-ΔC655.F645A.UAS, Scer\GAL4NP5130
brJF02585/Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of Scer\GAL4NP5130, uspHMS01620
brJF02585, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of Oatp74DRNAi.UAS.cUa, Scer\GAL4NP5130
brJF02585, Scer\GAL4NP5130 is a suppressor of abnormal cell number | P-stage phenotype of Eip93FHMC04773, Scer\GAL4NP5130
brJF02585, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of EcRB1-ΔC655.F645A.UAS, Scer\GAL4NP5130
brJF02585/Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of Scer\GAL4NP5130, uspHMS01620
brJF02585, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of Oatp74DRNAi.UAS.cUa, Scer\GAL4NP5130
brJF02585, Scer\GAL4NP5130 is a suppressor of enteroendocrine cell | P-stage | decreased number phenotype of Eip93FHMC04773, Scer\GAL4NP5130